Caplin Point Laboratories has informed the exchanges that officials of European Union GMP had recently carried out inspection of the company’s sterile injectable facility (Unit IV). The outcome of the inspection is very positive and it is likely that approval may be accorded shortly, the company said in the notification. Shares of Caplin Point Laboratories on the NSE closed at ₹884.95, down 0.7 per cent over the previous day’s close.
European Union GMP officials inspect Caplin Point sterlite injectable unit
Published on
March 24, 2015 16:41
Tags